Display Settings:

Format

Send to:

Choose Destination

    Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2898-903. Epub 2005 Feb 11.

    T cells from epicutaneously immunized mice are prone to T cell receptor revision.

    Bynoe MS, Viret C, Flavell RA, Janeway CA Jr.

    Section of Immunobiology, Howard Hughes Medical Institute and Yale University School of Medicine, New Haven, CT 06520, USA. margaret.bynoe@yale.edu

    Epicutaneous immunization of T cell receptor (TCR) transgenic (Tg) mice whose CD4(+) T cells are specific for the Ac1-11 fragment of myelin basic protein (MBP) with Ac1-11 elicits T cells with dominant suppressor/regulatory activity that confers protection against Ac1-11-induced experimental autoimmune encephalomyelitis. We now report that such disease-resistant MBP TCR Tg mice also harbor a sizeable fraction of peripheral CD4(+) T cells lacking surface expression of the Tg TCR beta chain and expressing diverse, endogenously rearranged TCR beta chains. Ex vivo incubation at physiological temperature caused the loss of neo-beta-chain expression and reversion to the MBP alphabeta TCR(+) phenotype. The presence of recombination activating gene 1 and 2 proteins in CD4(+) T cells with revised TCRs was consistent with effective V(D)J recombination activity. The emergence of these cells did not depend on the thymic compartment. We conclude that in mice epicutaneously immunized with an autoantigen, peripheral specific T cells are susceptible to multiple mechanisms of tolerance.

    PMID: 15708975 [PubMed - indexed for MEDLINE]

    PMCID: 549496

    Supplemental Content

    Click here to read Click here to read Click here to read Click here to read Click here to read